Good news for DNI's graphite wholesale

New Post Public Reply Private Reply Replies (0) Message Board
Luke_McCain
416
Good news for DNI's graphite wholesale business...

Quote:
2017-02-03T12:58:11+00:00
TORONTO, ONTARIO--(Marketwired - Feb. 3, 2017) - Great Lakes Graphite Inc. ("GLK" or the "Company" (TSX VENTURE:GLK)(OTC PINK:GLKIF)(FRANKFURT:8GL) announces today that the Company has received a purchase order for 400 kilograms of micronized natural flake graphite from a large corporation headquartered in Western Europe with two production facilities in North America and a third production facility in the Middle East. The customer was provided with an initial sample of two kilograms of material for qualification testing and is now purchasing a larger quantity to conduct production-scale qualification tests.


Great Lakes purchases all of their natural flake graphite from DNI Metals Inc. (See old post for PR/agreement)

Quote:
Great Lakes Graphite Chief Executive Officer Paul Gorman said, "We are excited to be working with this customer for a number of reasons. The customer represents new markets for us, both geographically and also in terms of the targeted application set. We have been enjoying strong early success with our synthetic graphite products and are now gearing up marketing efforts for our natural flake graphite products. We are continuing to work through our partners to manage the production of these initial orders and are able to do so until such time as we are prepared to initiate and transition manufacturing operations to the Matheson facility."


After this, there should be one more "small" order for 20 metric tons, and then the real orders begin.

This potential client sounds big enough where they could order hundreds of metric tons on a monthly or semi-monthly basis, leading to a nice revenue stream.

DNI Metals Inc. (DMNKF) Stock Research Links

DMNKF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading